EU urges US to join new Mideast peace effort

European High Representative of the Union for Foreign Affairs, Josep Borrell speaks during a media conference after a meeting of EU foreign ministers by videoconference at the European Council building in Brussels on June 15, 2020. (AFP)
Short Url
Updated 15 June 2020

EU urges US to join new Mideast peace effort

  • Josep Borrell said the Europeans want peace talks to resume
  • He insisted that any new initiative must respect the “internationally agreed parameters”

BRUSSELS: European Union foreign ministers on Monday urged the United States to join a new effort to breathe life into long-stalled peace talks between Israel and the Palestinians, but they rejected President Donald Trump’s Middle East plan as the basis for any international process.
Trump’s proposal, which was unveiled in January, would foresee the eventual creation of a Palestinian state, but it falls far short of minimal Palestinian demands and would leave sizable chunks of the occupied West Bank in Israeli hands.
Speaking after chairing video talks between the ministers and US Secretary of State Mike Pompeo, EU foreign policy chief Josep Borrell said the Europeans “recognize the merit of the US plan because it has created a certain momentum where there was nothing.”
“This momentum can be used to start a joint international effort of the basis of existing internationally agreed parameters,” Borrell said, referring to the need for a two-state solution, based along the 1967 lines, with the possibility of mutually agreed land-swaps.
“We made clear that it is important to encourage the Israelis and the Palestinians to engage in a credible and meaningful political process,” Borrell said. “For us, there is no other way than to resume talks.” But he insisted that any new initiative must respect the “internationally agreed parameters.”
Trump’s plan was welcomed by Israeli Prime Minister Benjamin Netanyahu, but Palestinian President Mahmoud Abbas dismissed it as “nonsense.” Gulf Arab states also rejected the White House plan as “biased.” While Israeli officials were present for its unveiling, no Palestinian representatives attended.
German Foreign Minister Heiko Maas also insisted on the need “to revive the peace process in the region and find a way for both sides to speak and negotiate with each other.”
“A multilateral format could certainly be the right framework for this, and we are prepared to support any initiative in this direction — and I would be glad if our colleague from Washington also were prepared to do this,” Maas said. No details of what the new effort might look like were provided.
Netanyahu has said that he wants to move forward with plans to annex parts of the West Bank, perhaps in early July, and Borrell said the ministers warned Pompeo about “the consequences of a possible annexation for the prospects of a two-state solution but also for regional stability.”
In recent months, the 27-nation bloc has debated whether to modify its Middle East policy amid growing concern that settlement activity and US diplomatic moves, like the recognition of Jerusalem as Israel’s capital, are undermining the chances of a two-state solution.
But while the EU is the biggest provider of aid to the Palestinians, the member countries have little obvious leverage over Israel that they would be prepared to use, and it’s unclear what action, if any, they would take should Netanyahu push ahead with his annexation plan.


US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

Updated 34 min 3 sec ago

US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.